Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
Lymphatic malformations (LMs) are congenital vascular anomalies characterized by abnormal lymphatic development, leading to ...
The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
Robust target engagement was observed, with statistically significant increases in regulatory T-cell (Treg) suppressive function and Treg numbers beginning as early as two weeks post-dosing and ...
This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...
Research has been increasingly interested in Urolithin A for some time. It is a so-called postbiotic that our gut bacteria ...
A 200,000-year-old molar from Denisova Cave has provided a glimpse into the life of Denisovans, revealing startling new ...
Researchers at King's have been awarded £2.1m in funding to take a new regenerative, cell-based therapy for leg pain caused by reduced blood flow to ...
Key 2026 milestones for SeaStar Medical include the following: Broaden QUELIMMUNE adoption to include 15 additional top-ranked children’s medical centers, more than doubling the total number of sites ...